Skip to main content
. 2023 Jul 21;15(14):3704. doi: 10.3390/cancers15143704

Figure 7.

Figure 7

Effects of HybridTherm Probe ablation plus chemotherapy (HTP-CT arm) over chemotherapy alone (CT arm) on immune cells and cytokines after 4 months of therapy. The mean percentage of circulating CD4+ T regulatory cells (A), CD45+ monocytes (B), CD45+ classic monocytes (C), and CD45+ inflammatory monocytes (D) were significantly lower at 4 months in HTP-CT arm than CT arm. The mean concentration of soluble A proliferation-inducing ligand/tumor necrosis factor ligand superfamily member 13 (APRIL/TNFSF13) (E) was significantly lower at 4 months in HTP-CT arm than CT arm. Inter-group variables were compared using the Welch two sample t-test: significant (*) = p < 0.05.